Zeon Lifesciences Expands Its Footprints In Global Market

Zeon Lifesciences India’s largest Contract Research and Manufacturing Services (CRAMS) Organization has announced its further expansion to over 13 countries in the FY 2023-24 after having made its significant presence across various regions including SEA, MENA, GEC, with its wide array of Nutrition Wellness and Ayurvedic products.

Committed to its mission of nurturing life with well-researched health and wellness products, the company is set to expand with its line of products, compliant with the highest safety & efficacy standards and more than 15 accreditations such as US FDA registered, NSF USA, SEDEX, WHO GMP, Ministry of Ayush, FSSAI, NABL Quality Lab, DSIR certified R&D among others.

With an extensive focus on innovation, Zeon has collaborated with the country’s many top research organisations, academic associations, and agencies for technology transfer, patent filing, and clinical validation. The company possesses over over 250 formulations and more than 625 product Stock Keeping Units (SKUs) in various categories, including General, Functional, Disease-specific, Nutraceuticals, Performance, Phyto-nutrition, Veterinary, and Ayurvedic Proprietary Medicine Products among others.

According to the statement, the brand has also commercialised various premium nutraceutical and herbal product categories in human and pet animal nutrition including ‘formulated sublingual sprays’, ‘Enzyme syrup for gut health’, ‘pet nutrition products.
 
Commenting on the growth and the future plans Yashna Garg, CMO at Zeon Lifesciences says “Since India is becoming a hub for nutraceutical products, it is a broader chance for us to consider this opportunity and provide the best of the product in the country. Hence, we are excited to introduce new categories that we have been developing and testing. We hope that these categories will benefit the masses.”

 “We are committed to staying at the forefront of innovation and new technology in this space and believe that our ongoing investments in research and development will enable us to continue to bring new and exciting products to market. We look forward to sharing more updates on our product diversification plans in the near future” She added.

Zeon has a State- of- the art manufacturing facility at Paonta Sahib, Himachal Pradesh, spread across 28,000sq. Yards. Also, Zeon life science has products registered under COPP and many more in the pipeline for launching in various countries. Certificate of Pharmaceutical Product, is a document issued by a national regulatory authority to certify that the product has been authorised for sale in a particular country or region. It serves as proof that the product has met the regulatory requirements of that country or region and is safe, effective, and of good quality.

COPP is commonly required for products to be imported, exported, or registered in various countries.  Zeon Lifescience also has products registered under WHO-GMP for Ayurvedic products and signifies their commitment to quality and regulatory compliance as per the guidance of the Ministry of Ayush.